BioCentury
ARTICLE | Clinical News

THR-100: Phase III start

May 19, 2008 7:00 AM UTC

In 3Q08, Bharat will begin an Indian Phase III trial. ThromboGenics granted Bharat an exclusive license to develop and commercialize THR-100 to treat AMI in developing and certain industrialized count...